MedTrace Logo

Safety and Efficacy of Herbmed Plus in Patients withRenal Calculi

NCT01355341 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 84

Last updated 2011-05-18

No results posted yet for this study

Summary

More specifically, the present invention relates to a 'Herbal Preparation' that is useful for

* Treatment of Renal calculi
* Reduction in the stone size \& surface area
* The expulsion of stone
* Decreased need of Analgesic(Antiinflammatory Effect)
* Stops the recurrence and reformation of renal

Conditions

  • RENAL CALCULI

Interventions

DRUG

HERBMED PLUS

500 mg Twice day for 6 month with lunch and dinner.

Sponsors & Collaborators

  • Amai Charitable Trust

    lead OTHER

Principal Investigators

  • SURESH B PATANKAR, MS.Mch. · AMAI CHRITABLE TRUST'S ACE HOSPITAL

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
10 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-04-30
Primary Completion
2011-12-31
Completion
2011-12-31

Countries

  • India

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01355341 on ClinicalTrials.gov